Melatonin pretreatment can improve the therapeutic effect of adipose-derived stem cells on CCl₄-induced liver fibrosis

References

• Alfaifi, M., et al., 2018. Mesenchymal stromal cell therapy for liver diseases. Journal of hepatology, 68 (6), 1272–1285.
   PubMed Web of Science ®Google Scholar
• An, S.Y., et al., 2017. Milk fat globule-EGF factor 8, secreted by mesenchymal stem cells, protects against liver fibrosis in mice. Gastroenterology, 152 (5), 1174–1186.
   PubMed Web of Science ®Google Scholar
• Ang, L.T., et al., 2018. A roadmap for human liver differentiation from pluripotent stem cells. Cell reports, 22 (8), 2190–2205.
   PubMed Web of Science ®Google Scholar
• Arthur, M.J., 2000. Fibrogenesis II. Metalloproteinases and their inhibitors in liver fibrosis. American journal of physiology. Gastrointestinal and liver physiology, 279 (2), G245–249.
   PubMed Web of Science ®Google Scholar
• Banas, A., et al., 2008. Rapid hepatic fate specification of adipose-derived stem cells and their therapeutic potential for liver failure. Journal of gastroenterology and hepatology, 24 (1), 70–77.
   PubMed Web of Science ®Google Scholar
• Bandi, S., Tchaikovskaya, T., and Gupta, S., 2019. Hepatic differentiation of human pluripotent stem cells by developmental stage-related metabolomics products. Differentiation; research in biological diversity, 105, 54–70.
   PubMed Web of Science ®Google Scholar
• Bi, Y., et al., 2019a. Human liver stem cells attenuate concanavalin A-induced acute liver injury by modulating myeloid-derived suppressor cells and CD4(+) T cells in mice. Stem cell research & therapy, 10 (1), 22.
   PubMedGoogle Scholar
• Bi, Y., et al., 2019b. Transplanted adult human hepatic stem/progenitor cells prevent histogenesis of advanced hepatic fibrosis in mice induced by carbon tetrachloride. American Journal of Translational Research, 11, 2350–2358.
   PubMed Web of Science ®Google Scholar
• Burst, V.R., et al., 2010. Poor cell survival limits the beneficial impact of mesenchymal stem cell transplantation on acute kidney injury. Nephron. Experimental nephrology, 114 (3), e107-116–e116.
   Google Scholar
• Cai, P., et al., 2019. The toxicity and safety of traditional Chinese medicines: please treat with rationality. Bioscience trends, 13 (5), 367–373.
   PubMed Web of Science ®Google Scholar
• Cassidy, A., and Minihane, A.M., 2017. The role of metabolism (and the microbiome) in defining the clinical efficacy of dietary flavonoids. The American journal of clinical nutrition, 105 (1), 10–22.
   PubMed Web of Science ®Google Scholar
• Chandra, S., et al., 2021. Epigenetics and expression of key genes associated with cardiac fibrosis: NLRP3, MMP2, MMP9, CCN2/CTGF and AGT. Epigenomics, 13 (3), 219–234.
   PubMedGoogle Scholar
• Chen, D., et al., 2017. Bright polymer dots tracking stem cell engraftment and migration to injured mouse liver. Theranostics, 7 (7), 1820–1834.
   PubMed Web of Science ®Google Scholar
• Chen, Y., et al., 2020. Baihe Wuyao decoction ameliorates CCl(4)-induced chronic liver injury and liver fibrosis in mice through blocking TGF-β1/Smad2/3 signaling, anti-inflammation and anti-oxidation effects. Journal of ethnopharmacology, 263, 113227.
   PubMed Web of Science ®Google Scholar
• Cho, I.J., et al., 2010. E-cadherin antagonizes transforming growth factor β1 gene induction in hepatic stellate cells by inhibiting RhoA-dependent Smad3 phosphorylation. Hepatology, 52 (6), 2053–2064.
   PubMed Web of Science ®Google Scholar
• Cho, Y.A., et al., 2015. Melatonin promotes hepatic differentiation of human dental pulp stem cells: clinical implications for the prevention of liver fibrosis. Journal of pineal research, 58 (1), 127–135.
   PubMed Web of Science ®Google Scholar
• Don, C.W., and Murry, C.E., 2013. Improving survival and efficacy of pluripotent stem cell-derived cardiac grafts. Journal of cellular and molecular medicine, 17 (11), 1355–1362.
   PubMed Web of Science ®Google Scholar
• du Souich, P., Roederer, G., and Dufour, R., 2017. Myotoxicity of statins: Mechanism of action. Pharmacology & therapeutics, 175, 1–16.
   PubMed Web of Science ®Google Scholar
• Dudás, J., et al., 2001. Expression of decorin, transforming growth factor-beta 1, tissue inhibitor metalloproteinase 1 and 2, and type IV collagenases in chronic hepatitis. American journal of clinical pathology, 115 (5), 725–735.
   PubMed Web of Science ®Google Scholar
• Eom, Y.W., Shim, K.Y., and Baik, S.K., 2015. Mesenchymal stem cell therapy for liver fibrosis. The Korean journal of internal medicine, 30 (5), 580–589.
   PubMed Web of Science ®Google Scholar
• Fallowfield, J.A., and Iredale, J.P., 2004. Targeted treatments for cirrhosis. Expert opinion on therapeutic targets, 8 (5), 423–435.
   PubMed Web of Science ®Google Scholar
• Fang, J., et al., 2018. Melatonin prevents senescence of canine adipose-derived mesenchymal stem cells through activating NRF2 and inhibiting ER stress. Aging, 10 (10), 2954–2972.
   PubMedGoogle Scholar
• Fisher, E.S., and Curry, S.C., 2019. Evaluation and treatment of acetaminophen toxicity. Advances in pharmacology 85, 263–272.
   PubMedGoogle Scholar
• Fu, J., et al., 2011. Melatonin promotes proliferation and differentiation of neural stem cells subjected to hypoxia in vitro. Journal of pineal research, 51 (1), 104–112.
   PubMed Web of Science ®Google Scholar
• Fukazawa, K., and Nishida, S., 2016. Size mismatch in liver transplantation. Journal of hepato-biliary-pancreatic sciences, 23 (8), 457–466.
   PubMed Web of Science ®Google Scholar
• Gage, B.K., et al., 2020. Generation of functional liver sinusoidal endothelial cells from human pluripotent stem-cell-derived venous angioblasts. Cell stem cell, 27 (2), 254–269.e9. e259.
   PubMed Web of Science ®Google Scholar
• Gao, W., et al., 2014. Melatonin enhances chondrogenic differentiation of human mesenchymal stem cells. Journal of pineal research, 56 (1), 62–70.
   PubMed Web of Science ®Google Scholar
• Ghosheh, N., et al., 2017. Comparative transcriptomics of hepatic differentiation of human pluripotent stem cells and adult human liver tissue. Physiological genomics, 49 (8), 430–446.
   PubMed Web of Science ®Google Scholar
• Hernandez-Gea, V., and Friedman, S.L., 2011. Pathogenesis of liver fibrosis. Annual review of pathology: mechanisms of disease, 6 (1), 425–456.
   PubMedGoogle Scholar
• Jiaqi, C., et al., 2016. Effects of melatonin and its analogues on neural stem cells. Molecular cellular endocrinology, 420, 169–179.
   PubMed Web of Science ®Google Scholar
• Kim, P.H., et al., 2015. Stanniocalcin 2 enhances mesenchymal stem cell survival by suppressing oxidative stress. BMB reports, 48 (12), 702–707.
   PubMed Web of Science ®Google Scholar
• Kirchner, V.A., et al., 2020. Current status of liver transplantation in North America. International Journal of Surgery, 82s, 9–13.
   PubMedGoogle Scholar
• Kopp, J.L., Grompe, M., and Sander, M., 2016. Stem cells versus plasticity in liver and pancreas regeneration. Nature cell biology, 18 (3), 238–245.
   PubMed Web of Science ®Google Scholar
• Kränkel, N., et al., 2011. Targeting stem cell niches and trafficking for cardiovascular therapy. Pharmacology & Therapeutics, 129 (1), 62–81.
   PubMed Web of Science ®Google Scholar
• Kumar, A., et al., 2012. Effect of mitotic inducers and retinoic acid blocker on expression of pluripotent genes in ES cells derived from early stage in vitro-produced embryos in buffalo. In vitro cellular & developmental biology. animal, 48 (10), 625–632.
   PubMed Web of Science ®Google Scholar
• Lambrecht, J., van Grunsven, L.A., and Tacke, F., 2020. Current and emerging pharmacotherapeutic interventions for the treatment of liver fibrosis. Expert opinion on pharmacotherapy, 21 (13), 1637–1650.
   PubMed Web of Science ®Google Scholar
• Lee, J.H., Han, Y.S., and Lee, S.H., 2020a. Melatonin-induced PGC-1α improves angiogenic potential of mesenchymal stem cells in hindlimb ischemia. Biomolecules & therapeutics, 28 (3), 240–249.
   PubMed Web of Science ®Google Scholar
• Lee, J.H., et al., 2020b. Melatonin suppresses senescence-derived mitochondrial dysfunction in mesenchymal stem cells via the HSPA1L-mitophagy pathway. Aging cell, 19 (3), e13111.
   PubMed Web of Science ®Google Scholar
• Li, X., et al., 2018. A comprehensive review and perspectives on pharmacology and toxicology of saikosaponins. Phytomedicine : international journal of phytotherapy and phytopharmacology, 50, 73–87.
   PubMed Web of Science ®Google Scholar
• Li, X.M., et al., 2016. Chinese medicine CGA formula ameliorates DMN-induced liver fibrosis in rats via inhibiting MMP2/9, TIMP1/2 and the TGF-β/Smad signaling pathways. Acta pharmacologica Sinica, 37 (6), 783–793.
   PubMed Web of Science ®Google Scholar
• Liao, N., et al., 2020. Antioxidant preconditioning improves therapeutic outcomes of adipose tissue-derived mesenchymal stem cells through enhancing intrahepatic engraftment efficiency in a mouse liver fibrosis model. Stem cell research & therapy, 11 (1), 237.
   PubMed Web of Science ®Google Scholar
• Liu, C., et al., 2020. Melatonin protects neural stem cells against tri-ortho-cresyl phosphate-induced autophagy. Frontiers in Molecular Neuroscience, 13, 25.
   PubMed Web of Science ®Google Scholar
• Liu, Y., et al., 2018. Breviscapine ameliorates CCl4‑induced liver injury in mice through inhibiting inflammatory apoptotic response and ROS generation. International journal of molecular medicine, 42 (2), 755–768.
   PubMed Web of Science ®Google Scholar
• Loh, K.M., Palaria, A., and Ang, L.T., 2019. Efficient differentiation of human pluripotent stem cells into liver cells. Journal of visualized experiments, (148), e58975.
   PubMed Web of Science ®Google Scholar
• Long, T., et al., 2019. Protective effects of trans-2,3,5,4'-tetrahydroxystilbene 2-O-β-d-glucopyranoside on liver fibrosis and renal injury induced by CCl(4)via down-regulating p-ERK1/2 and p-Smad1/2. Food & function, 10 (8), 5115–5123.
   PubMed Web of Science ®Google Scholar
• Lou, G., et al., 2017. Mesenchymal stem cell-derived exosomes as a new therapeutic strategy for liver diseases. Experimental & molecular medicine, 49 (6), e346.
   PubMed Web of Science ®Google Scholar
• Ma, J., et al., 2019. Locostatin alleviates liver fibrosis induced by carbon tetrachloride in mice. Digestive diseases and sciences, 64 (9), 2570–2580.
   PubMed Web of Science ®Google Scholar
• Mahmoud, Y.I., and Mahmoud, A.A., 2016. Role of nicotinamide (vitamin B3) in acetaminophen-induced changes in rat liver: Nicotinamide effect in acetaminophen-damged liver. Experimental and toxicologic pathology : official journal of the Gesellschaft fur Toxikologische Pathologie, 68 (6), 345–354.
   PubMedGoogle Scholar
• Margheri, M., et al., 2012. Combined effects of melatonin and all-trans retinoic acid and somatostatin on breast cancer cell proliferation and death: Molecular basis for the anticancer effect of these molecules. European journal of pharmacology, 681 (1-3), 34–43.
   PubMed Web of Science ®Google Scholar
• Marslin, G., Et al., 2018. Oral delivery of curcumin polymeric nanoparticles ameliorates CCl4-induced Subacute hepatotoxicity in Wistar rats. Polymers, 10 (5), 541.
   PubMed Web of Science ®Google Scholar
• Mazo, D.F., et al., 2013. S-nitroso-N-acetylcysteine attenuates liver fibrosis in experimental nonalcoholic steatohepatitis. Drug Design, Development and Therapy, 7, 553–563.
   PubMed Web of Science ®Google Scholar
• Mortezaee, K., 2018. Human hepatocellular carcinoma: protection by melatonin. Journal of cellular physiology, 233 (10), 6486–6508.
   PubMed Web of Science ®Google Scholar
• Mortezaee, K., and Khanlarkhani, N., 2017. Melatonin application in targeting oxidative-induced liver injuries: a review. Journal of cellular physiology, 233 (5), 4015–4032.
   PubMed Web of Science ®Google Scholar
• Mortezaee, K., et al., 2017. Preconditioning with melatonin improves therapeutic outcomes of bone marrow-derived mesenchymal stem cells in targeting liver fibrosis induced by CCl4. Cell and tissue research, 369 (2), 303–312.
   PubMed Web of Science ®Google Scholar
• Moya, A., et al., 2018. Human mesenchymal stem cell failure to adapt to glucose shortage and rapidly use intracellular energy reserves through glycolysis explains poor cell survival after implantation. Stem cells, 36 (3), 363–376.
   PubMed Web of Science ®Google Scholar
• Nazhvani, F.D., et al., 2020. Regenerative effect of mesenteric fat stem cells on ccl4-induced liver cirrhosis, an experimental study. Annals of medicine and surgery (2012), 60, 135–139.
   PubMed Web of Science ®Google Scholar
• Pedroza, M., et al., 2019. Cadherin-11 contributes to liver fibrosis induced by carbon tetrachloride. PLOS One, 14 (7), e0218971.
   PubMed Web of Science ®Google Scholar
• Piek, E., Heldin, C.H., and Ten Dijke, P., 1999. Specificity, diversity, and regulation in TGF-beta superfamily signaling. FASEB journal : official publication of the Federation of American societies for experimental biology, 13 (15), 2105–2124.
   PubMed Web of Science ®Google Scholar
• Ping, J., et al., 2018. Effect of bone marrow mesenchymal stem cell transplantation on CCl4-induced liver injury in rats and intervention effects of Yiguanjian. . Zhongguo Zhong Yao Za Zhi, 43, 3905–3912.
   PubMedGoogle Scholar
• Povero, D., et al., 2019. Human induced pluripotent stem cell-derived extracellular vesicles reduce hepatic stellate cell activation and liver fibrosis. JCI Insight, 4 (14), e125652.
   Web of Science ®Google Scholar
• Radio, N.M., Doctor, J.S., and Witt-Enderby, P.A., 2006. Melatonin enhances alkaline phosphatase activity in differentiating human adult mesenchymal stem cells grown in osteogenic medium via MT2 melatonin receptors and the MEK/ERK (1/2) signaling cascade. Journal of pineal research, 40 (4), 332–342.
   PubMed Web of Science ®Google Scholar
• Regmi, S., et al., 2019. Intraportally delivered stem cell spheroids localize in the liver and protect hepatocytes against GalN/LPS-induced fulminant hepatic toxicity. Stem cell research & therapy, 10 (1), 230.
   PubMed Web of Science ®Google Scholar
• Rong, X., et al., 2019. Human bone marrow mesenchymal stem cells-derived exosomes alleviate liver fibrosis through the Wnt/β-catenin pathway. Stem cell research & therapy, 10 (1), 98.
   PubMedGoogle Scholar
• Saberi, K., et al., 2019. Melatonin preconditioning of bone marrow-derived mesenchymal stem cells promotes their engraftment and improves renal regeneration in a rat model of chronic kidney disease. Journal of molecular histology, 50 (2), 129–140.
   PubMed Web of Science ®Google Scholar
• Shibo, L., et al., 2017. Melatonin promotes sorafenib-induced apoptosis through synergistic activation of JNK/c-jun pathway in human hepatocellular carcinoma. Journal of pineal research, 62 (3), e12398.
   Web of Science ®Google Scholar
• Strem, B.M., et al., 2005. Multipotential differentiation of adipose tissue-derived stem cells. The Keio journal of medicine, 54 (3), 132–141.
   PubMedGoogle Scholar
• Sun, M., and Kisseleva, T., 2015. Reversibility of liver fibrosis. Clinics and research in hepatology and gastroenterology, 39 (Suppl 1), S60–S63.
   PubMed Web of Science ®Google Scholar
• Tang, W.P., et al., 2018. [Effect of adipose tissue-derived mesenchymal stem cell transplantation in treatment of liver fibrosis and possible mechanism]. Zhonghua gan zang bing za zhi = Zhonghua ganzangbing zazhi = Chinese journal of hepatology, 26 (1), 28–33.
   PubMedGoogle Scholar
• Tang, Y., et al., 2014. Melatonin pretreatment improves the survival and function of transplanted mesenchymal stem cells after focal cerebral ischemia. Cell transplantation, 23 (10), 1279–1291.
   PubMed Web of Science ®Google Scholar
• Wang, Q., et al., 2019. Dynamic features of liver fibrogenesis and fibrosis resolution in the absence of matrix metalloproteinase‑9. Molecular medicine reports, 20, 5239–5248.
   PubMed Web of Science ®Google Scholar
• Wang, X., et al., 2021. Anti-inflammatory, antioxidant, and antifibrotic effects of gingival-derived mscs on bleomycin-induced pulmonary fibrosis in mice. International Journal of Molecular Sciences, 23 (1), 99.
   Web of Science ®Google Scholar
• Watanabe, Y., et al., 2019. Mesenchymal stem cells and induced bone marrow-derived macrophages synergistically improve liver fibrosis in mice. Stem cells translational medicine, 8 (3), 271–284.
   PubMed Web of Science ®Google Scholar
• Wu, H., et al., 2016. Research progress on potential liver toxic components in traditional Chinese medicine. Zhongguo Zhong yao za zhi = Zhongguo zhongyao zazhi =. China journal of Chinese materia medica, 41, 3209–3217.
   Google Scholar
• Xu, Y., et al., 2014. Artesunate ameliorates hepatic fibrosis induced by bovine serum albumin in rats through regulating matrix metalloproteinases. European journal of pharmacology, 744, 1–9.
   PubMed Web of Science ®Google Scholar
• Yang, F., et al., 2017. Melatonin protects bone marrow mesenchymal stem cells against iron overload-induced aberrant differentiation and senescence. Journal of pineal research, 63 (3), e12422.
   Web of Science ®Google Scholar
• Yu, S., et al., 2019. Melatonin promotes proliferation of neural stem cells from adult mouse spinal cord via the PI3K/AKT signaling pathway. FEBS letters, 593 (14), 1751–1762.
   PubMed Web of Science ®Google Scholar
• Zhang, Y., et al., 2020. Melatonin Rescues the Ti Particle-Impaired Osteogenic Potential of Bone Marrow Mesenchymal Stem Cells via the SIRT1/SOD2 Signaling Pathway. Calcified tissue international, 107 (5), 474–488.
   PubMed Web of Science ®Google Scholar
• Zhang, Z., and Wang, F.S., 2013. Stem cell therapies for liver failure and cirrhosis. Journal of hepatology, 59 (1), 183–185.
   PubMed Web of Science ®Google Scholar
• Zhao, L., et al., 2019. Preconditioning strategies for improving the survival rate and paracrine ability of mesenchymal stem cells in acute kidney injury. Journal of cellular and molecular medicine, 23 (2), 720–730.
   PubMed Web of Science ®Google Scholar
• Zuk, P.A., et al., 2001. Multilineage cells from human adipose tissue: implications for cell-based therapies. Tissue engineering Part engineering A, 7 (2), 211–228.
   PubMedGoogle Scholar